Inspire Investing LLC Lowers Position in Omega Healthcare Investors, Inc. (NYSE:OHI)

Inspire Investing LLC lessened its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 13.1% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 55,601 shares of the real estate investment trust’s stock after selling 8,347 shares during the period. Inspire Investing LLC’s holdings in Omega Healthcare Investors were worth $2,263,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the stock. Hennion & Walsh Asset Management Inc. lifted its position in shares of Omega Healthcare Investors by 96.7% during the 1st quarter. Hennion & Walsh Asset Management Inc. now owns 21,799 shares of the real estate investment trust’s stock valued at $690,000 after buying an additional 10,714 shares in the last quarter. Slagle Financial LLC lifted its position in shares of Omega Healthcare Investors by 102.1% during the 4th quarter. Slagle Financial LLC now owns 94,586 shares of the real estate investment trust’s stock valued at $2,900,000 after buying an additional 47,785 shares in the last quarter. Private Advisor Group LLC lifted its position in shares of Omega Healthcare Investors by 6.6% during the 1st quarter. Private Advisor Group LLC now owns 28,772 shares of the real estate investment trust’s stock valued at $911,000 after buying an additional 1,783 shares in the last quarter. Park Avenue Securities LLC lifted its position in shares of Omega Healthcare Investors by 5.7% during the 1st quarter. Park Avenue Securities LLC now owns 10,066 shares of the real estate investment trust’s stock valued at $319,000 after buying an additional 544 shares in the last quarter. Finally, HighPoint Advisor Group LLC purchased a new position in shares of Omega Healthcare Investors during the 4th quarter valued at approximately $758,000. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Insider Buying and Selling

In related news, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.19, for a total transaction of $905,962.98. Following the completion of the sale, the chief financial officer now directly owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, COO Daniel J. Booth sold 56,725 shares of the firm’s stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total transaction of $2,283,181.25. Following the completion of the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of the firm’s stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company’s stock.

Analysts Set New Price Targets

OHI has been the topic of a number of recent analyst reports. Wells Fargo & Company reiterated an “overweight” rating and set a $43.00 target price (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. BMO Capital Markets increased their price objective on Omega Healthcare Investors from $44.00 to $45.00 and gave the company a “market perform” rating in a research note on Monday, October 7th. Mizuho downgraded Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and increased their price objective for the company from $34.00 to $35.00 in a research note on Thursday, July 25th. Truist Financial increased their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research note on Wednesday, September 4th. Finally, Scotiabank increased their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research note on Monday, August 26th. Eight research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, Omega Healthcare Investors presently has an average rating of “Hold” and a consensus price target of $37.00.

Omega Healthcare Investors Stock Up 0.5 %

Shares of OHI opened at $39.78 on Friday. Omega Healthcare Investors, Inc. has a 52-week low of $27.53 and a 52-week high of $41.53. The company has a market capitalization of $9.83 billion, a PE ratio of 35.84, a price-to-earnings-growth ratio of 1.28 and a beta of 1.00. The stock has a fifty day simple moving average of $39.37 and a two-hundred day simple moving average of $34.93. The company has a quick ratio of 5.79, a current ratio of 5.79 and a debt-to-equity ratio of 1.19.

Omega Healthcare Investors (NYSE:OHI) last issued its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). The business had revenue of $252.70 million for the quarter, compared to analyst estimates of $205.92 million. Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The firm’s revenue for the quarter was up 17.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.74 earnings per share. As a group, equities analysts forecast that Omega Healthcare Investors, Inc. will post 2.69 EPS for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Monday, August 5th were given a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.74%. The ex-dividend date was Monday, August 5th. Omega Healthcare Investors’s payout ratio is 241.44%.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.